REGISTER NOW
Panelists:
Hans Clevers, MD, PhD
ProfessorStem Cell PioneerOrganoid ResearcherHubrecht Institute, the Netherlands
View Bio
Panelist
Hans Clevers, MD, PhD
Professor Hans Clevers, MD, PhD, is a professor at the Hubrecht Institute, which is an institute of the Royal Netherlands Academy of Arts and Sciences (KNAW) in the Dutch city of Utrecht. His group studies the molecular mechanisms of tissue development and cancer of various organs using organoids. His pioneering research on the developmental signaling pathway and led his group to major discoveries in the cancer and stem cell fields, ultimately resulting in technologies to grow human stem cells into mini-organs (organoids) in a dish. His research accomplishments have been recognized with the Louis Jeantet Prize and the Breakthrough Prize in Life Sciences, amongst many others. In March 2022, Hans was named head of the Roche Pharmaceutical Research and Early Development, a position he held for more than three years until returning to the Netherlands in August 2025.
Born and raised in the south of the Netherlands, Clevers studied biochemistry and medicine in Utrecht. After earning his PhD in immunology, Hans trained as a molecular biologist at Harvard. Back in Utrecht, he became professor in immunology at the university hospital, director of the Hubrecht Institute for developmental biology (2002), and finally research director of the Princess Máxima Center for childhood cancer (2015). As president of KNAW, he founded the Academy of Arts. Hans is a member of multiple learned societies including the KNAW, the National Academy of Sciences in the U.S., the Académie Française, the order Pour le Mérite of Germany, and the Royal Society. He holds knighthoods in Holland, France, and Germany.
Close
Broadcast Date: Wednesday, March 11, 2026Time: 09:00 PDT, 12:00 EDT, 16:00 GMTWelcome to the inaugural GEN Spotlight—a 2.5-hour virtual event on the dynamic field of Organoids.From neurodevelopment and brain research to cancer and drug development, researchers are using organoid models to unveil biological insights that were previously unattainable using traditional cell culture experiments or animal models. This research has profound implications for basic biomedical research and more applied therapeutic applications in drug discovery and development as well as cell- and tissue-replacement therapies. It also raises the prospect of a profound transformation in the process of drug development, as organoids could potentially supplant the use of animal models.In this inaugural GEN Spotlight on Organoids, hosted by Deputy Editor in Chief Julianna LeMieux, PhD, we are delighted to feature an exclusive fireside chat with renowned stem cell pioneer and organoid researcher Hans Clevers, MD, PhD, of the Hubrecht Institute in the Netherlands. The GEN Spotlight will also feature a roundtable discussion with leading researchers, a presentation from an industry thought leader, and a breakout session from one of our sponsors.We expect to attract a large international audience. Registration is absolutely free! The program will also be available to watch on demand following the live broadcast.Produced with support from:The post Spotlight on Organoids appeared first on GEN – Genetic Engineering and Biotechnology News.
